论文部分内容阅读
目的 研究结直肠癌患者腹腔液、血液中CK2 0mRNA对微转移预测的价值。方法 采用RT -PCR技术对 5 0例结直肠癌患者的腹腔液、血液进行CK2 0mRNA检测。结果 5 0例结直肠癌患者腹腔液CK 2 0mRNA阳性率为 5 2 % (2 6/5 0 ) ,血液CK2 0mRNA阳性率为 68%(3 4/5 0 ) ,10例结直肠良性病变均为阴性。结论 结直肠癌患者检测腹腔液和血液中的CK2 0mRNA对于预测腹腔和血液循环中的微转移 ,指导术后治疗有重要价值
Objective To study the value of CK20 mRNA in the prediction of micrometastasis in peritoneal fluid and blood of colorectal cancer patients. Methods The peritoneal fluid and blood samples from 50 patients with colorectal cancer were detected by RT-PCR. Results The positive rate of CK20 mRNA in peritoneal fluid was 52% (26/05) in colorectal cancer patients and 68% (34/500) in CK20 mRNA in colorectal cancer patients. All 10 cases of colorectal benign lesions Negative. Conclusion The detection of CK20 mRNA in peritoneal fluid and blood in patients with colorectal cancer is valuable for predicting micrometastases in the abdominal cavity and blood circulation and guiding postoperative treatment